Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans

Title
Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans
Authors
Keywords
Controlled Trial, Microbiome, Gastrointestinal Adverse Event, Prevention
Journal
GASTROENTEROLOGY
Volume 152, Issue 5, Pages 980-982.e3
Publisher
Elsevier BV
Online
2016-12-20
DOI
10.1053/j.gastro.2016.12.007

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More